← FDA Drug Approvals (Drugs@FDA)

DOXYCYCLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2017-07-28

Drug application

FDA Application #
ANDA209165
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOXYCYCLINE
Generic name
DOXYCYCLINE
Active ingredients
DOXYCYCLINE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
ALEMBIC
Manufacturer
Alembic Pharmaceuticals Limited
First approval
2017-07-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown